MedTrace Logo

DOvEE - Diagnosing Ovarian & Endometrial Cancer Early

NCT02296307 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 13600

Last updated 2024-05-02

No results posted yet for this study

Summary

This study hopes to improve early detection of ovarian and endometrial cancers. It will determine if women with bloating, abdominal distension, abdominal/pelvic pain, increased urinary frequency and/or early satiety, benefit from earlier surgery after screening by CA-125 ovarian cancer biomarker and transvaginal ultrasound.

Conditions

  • Ovarian Neoplasms

Interventions

OTHER

Blood test: CA-125 biomarker

* CA-125 biomarker blood test at visit 1, day 1. * CA-125 biomarker blood test at visit 2, week 6.

OTHER

Second Test: Transvaginal Ultrasound

-Transvaginal Ultrasound at visit 1, day 1.

OTHER

Follow-up phone call

Phone call 6 months after last visit to verify continued health.

Sponsors & Collaborators

Principal Investigators

  • Lucy Gilbert, MD,MSc,FRCOG · McGill University

Eligibility

Min Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2025-01-31
Completion
2026-01-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02296307 on ClinicalTrials.gov